pmid,title,journal,year,drug,disease
40607626,"Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2(V617F)-Positive Myeloproliferative Neoplasms.",Cancer medicine,2025,Ruxolitinib,Atrial Fibrillation
37343080,An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.,Science translational medicine,2023,Ruxolitinib,Atrial Fibrillation
34586561,Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic.,Current hematologic malignancy reports,2021,Ruxolitinib,Atrial Fibrillation
